Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Therapeutic Advances in Hematology|August 1, 2020
Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving conceptsOmar Castaneda Puglianini, Nikolaos PapadantonakisCancers|September 9, 2022
T-Cell-Based Cellular Immunotherapy of Multiple Myeloma: Current DevelopmentsGary L Simmons, Omar Castaneda PuglianiniDrugs in Context|October 4, 2021
Bispecific antibodies for non-Hodgkin's lymphomas and multiple myelomaOmar Castaneda-Puglianini, Julio C ChavezJournal of Blood Medicine|September 1, 2021
Assessing and Management of Neurotoxicity After CAR-T Therapy in Diffuse Large B-Cell LymphomaOmar Castaneda-Puglianini, Julio C ChavezSeminars in Hematology|September 21, 2024
CARs Moving Forward: The Development of CAR T-Cell Therapy in the Earlier Treatment Course of Hematologic MalignanciesOmar Castaneda Puglianini, Julio C ChavezBest Practice & Research. Clinical Haematology|October 9, 2021
Clinical experience of CAR T cells for multiple myelomaGary L Simmons, Toshihisa Satta, Omar Castaneda PuglianiniLaboratory Medicine|August 12, 2022
Essential Thrombocythemia and Post-Essential Thrombocythemia Myelofibrosis: Updates on Diagnosis, Clinical Aspects, and ManagementOmar Castaneda Puglianini, Deniz Peker, Linsheng Zhang, et al.Blood Advances|December 27, 2024
BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvementMahmoud R Gaballa, Omar Castaneda Puglianini, Adam Cohen, et al.Frontiers in Immunology|September 5, 2024
Cost-per-responder analysis of patients with lenalidomide-refractory multiple myeloma receiving ciltacabtagene autoleucel in CARTITUDE-4Doris K Hansen, Xiaoxiao Lu, Omar Castaneda Puglianini, et al.Expert Review of Pharmacoeconomics & Outcomes Research|February 24, 2026
Comparative cost per responder analysis of Ciltacabtagene autoleucel and real-world standard of Care therapy in patients with lenalidomide-refractory multiple myelomaDoris K Hansen, Xiaoxiao Lu, Omar Castaneda Puglianini, et al.Pageof 4